Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Santa Clara University's Master of Arts in Teaching and Teaching Credential (MATTC) program prepares teachers to examine and apply critical and socio-cultural theories to create equitable teaching and ...

Saint Louis University’s Gift Body Program is committed to excellence in research and education. The study of human anatomy has long been and continues to be essential to training physicians, physical ...

The Financial Sector Assessment Program (FSAP), established in 1999, is a comprehensive and in-depth assessment of a country’s financial sector. FSAPs in advanced economies are conducted by the IMF ...

Boston College will begin recruiting the first class for its highly anticipated Human-Centered Engineering program, a major that will integrate BC’s core liberal arts focus and a rigorous engineering ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...